Study reveals Pfizer bivalent COVID-19 booster safer for seniors against stroke risk compared to other vaccines

The comparative hazard of ischemic stroke (IS) in recipients of booster shots.

Non-viral delivery startup Vesigen Therapeutics trims staff as it evaluates ‘strategic options’

Cambridge, MA-based startup Vesigen Therapeutics is laying off staff and “evaluating strategic options,” CEO Paulash Mohsen confirmed to Endpoints News via email Friday afternoon. …

September 7, 2024

VA Expands Access to Virtual Reality Pain Therapy for Veterans

What You Should Know: – The U.S. Department of Veterans Affairs (VA) is taking a major step forward in pain management by expanding its contract

December 20, 2023

Aldeyra and AbbVie partner for reproxalap development

AbbVie has the option to obtain a co-exclusive licence for reproxalap’s development, manufacture and commercialisation in the US. Credit: Valeriya Zankovych / Shutterstock.com. Aldeyra Therapeutics

November 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.